Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000019617-25-000529·JPMORGAN CHASE & CO
Schedule 13G ownership disclosure
Radiopharm Theranostics Ltd
Ordinary Shares, as represented by American Depositary Shares · CUSIP: Q79455103
Event date: 2025-06-30
- Filing-level shares
- 220,480,943
- Percent of class
- 9.0%
- JPMORGAN CHASE & CO.
Shares: 220,480,943 · Class: 9.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000019617-25-000529
- Form type
- SCHEDULE 13G/A
- Filer
- JPMORGAN CHASE & CO
- CIK
- CIK 19617
- Filed
- Jul 16, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership